Developing immunoassays for human epidermal growth factor receptors 2, 3 and 4 and evaluating these receptors as tumour markers for HER2 positive breast cancer.
Developing assays for measuring different monoclonal antibodies used in the treatment of patients with autoimmune diseases. A collaboration study with the Department of Pharmacology and clinicians at Rikshospitalet and Diakonhjemmet.
Late effects after testicular cancer; thyroid and kidney function, in collaboration with National Advisory Unit on Late Effects after Cancer Treatment.
Establishing reference intervals for human chorionicgonadotropin (hCG).
Two dimensional chromatography combined with mass spectrometry is used to identify and quantitative tumour markers in collaboration with Dep. of Pharmaceutical Chemistry, UiO.
Part of the collaboration study “Hallmarks in lung cancer”; validating different markers for potential development of assays clinically useful in daily practice.
Recent publications
Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T(2019) The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway Eur Thyroid J, 8(3), 159-166 DOI 10.1159/000499018, PubMed 31259158
Kagan ZB, Mize JT, Kosta P, Lazzi G, Normann RA, Warren DJ(2019) Reduced Heat Generation During Magnetic Stimulation of Rat Sciatic Nerve Using Current Waveform Truncation IEEE Trans Neural Syst Rehabil Eng, 27(5), 937-946 DOI 10.1109/TNSRE.2019.2911054, PubMed 30990431
Dantas H, Warren DJ, Wendelken S, Davis T, Clark GA, Mathews VJ(2019) Deep Learning Movement Intent Decoders Trained with Dataset Aggregation for Prosthetic Limb Control IEEE Trans Biomed Eng(in press) DOI 10.1109/TBME.2019.2901882, PubMed 30835207